Hengehold Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.29M | Buy |
42,035
+1,041
| +3% | +$84K | 0.26% | 67 |
|
|
2026
Q1 | $3.55M | Buy |
40,994
+652
| +2% | +$62.5K | 0.31% | 62 |
|
|
2025
Q4 | $3.88M | Buy |
40,342
+747
| +2% | +$72.6K | 0.33% | 60 |
|
|
2025
Q3 | $3.77M | Buy |
39,595
+1,563
| +4% | +$144K | 0.32% | 61 |
|
|
2025
Q2 | $3.32M | Buy |
38,032
+161
| +0.4% | +$13.7K | 0.3% | 63 |
|
|
2025
Q1 | $3.4M | Buy |
37,871
+1,402
| +4% | +$125K | 0.32% | 59 |
|
|
2024
Q4 | $2.91M | Buy |
36,469
+468
| +1% | +$40.5K | 0.27% | 63 |
|
|
2024
Q3 | $3.24M | Buy |
36,001
+2,714
| +8% | +$228K | 0.31% | 63 |
|
|
2024
Q2 | $2.62M | Buy |
33,287
+483
| +1% | +$39.6K | 0.27% | 65 |
|
|
2024
Q1 | $2.86M | Buy |
32,804
+10,074
| +44% | +$860K | 0.3% | 63 |
|
|
2023
Q4 | $1.87M | Sell |
22,730
-436
| -2% | -$33.2K | 0.22% | 63 |
|
|
2023
Q3 | $1.82M | Buy |
23,166
+832
| +4% | +$69.6K | 0.24% | 62 |
|
|
2023
Q2 | $1.97M | Sell |
22,334
-36
| -0.2% | -$3.1K | 0.26% | 60 |
|
|
2023
Q1 | $1.8M | Buy |
22,370
+1,113
| +5% | +$90.7K | 0.25% | 61 |
|
|
2022
Q4 | $1.65M | Sell |
21,257
-9,811
| -32% | -$795K | 0.23% | 62 |
|
|
2022
Q3 | $2.51M | Sell |
31,068
-90
| -0.3% | -$8.09K | 0.39% | 48 |
|
|
2022
Q2 | $2.8M | Buy |
31,158
+1,920
| +7% | +$195K | 0.4% | 43 |
|
|
2022
Q1 | $3.24M | Buy |
29,238
+386
| +1% | +$40.8K | 0.44% | 38 |
|
|
2021
Q4 | $2.98M | Buy |
28,852
+693
| +2% | +$80.2K | 0.37% | 40 |
|
|
2021
Q3 | $3.53M | Buy |
28,159
+286
| +1% | +$37K | 0.46% | 34 |
|
|
2021
Q2 | $3.46M | Sell |
27,873
-30
| -0.1% | -$3.77K | 0.45% | 35 |
|
|
2021
Q1 | $3.3M | Buy |
27,903
+61
| +0.2% | +$7.15K | 0.46% | 37 |
|
|
2020
Q4 | $3.26M | Buy |
27,842
+30
| +0.1% | +$3.3K | 0.49% | 26 |
|
|
2020
Q3 | $2.89M | Sell |
27,812
-192
| -0.7% | -$19.3K | 0.47% | 27 |
|
|
2020
Q2 | $2.57M | Sell |
28,004
-578
| -2% | -$55.4K | 0.46% | 31 |
|
|
2020
Q1 | $2.58M | Sell |
28,582
-279
| -1% | -$29.7K | 0.55% | 25 |
|
|
2019
Q4 | $3.27M | Buy |
28,861
+214
| +0.7% | +$23.5K | 0.56% | 24 |
|
|
2019
Q3 | $3.11M | Sell |
28,647
-187
| -0.6% | -$19.5K | 0.57% | 25 |
|
|
2019
Q2 | $2.81M | Buy |
28,834
+404
| +1% | +$36.9K | 0.54% | 33 |
|
|
2019
Q1 | $2.59M | Buy |
28,430
+813
| +3% | +$72.8K | 0.61% | 33 |
|
|
2018
Q4 | $2.51M | Buy |
27,617
+1,759
| +7% | +$164K | 0.81% | 28 |
|
|
2018
Q3 | $2.54M | Buy |
25,858
+752
| +3% | +$69.5K | 0.64% | 30 |
|
|
2018
Q2 | $2.15M | Buy |
+25,106
| New | +$2.1M | 0.56% | 36 |
|
Other funds holding MDT
Hengehold Capital Management's MDT Position: Q2 2026 in Review
Hengehold Capital Management increased its Medtronic (MDT) stake by 2.5% in Q2 2026, buying an estimated $84K and bringing the position to 42,035 shares worth $3.29M. The position accounts for 0.26% of the portfolio, ranked #67.
Hengehold Capital Management first reported a position in MDT in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.88M in Q4 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Hengehold Capital Management held 42,035 shares of Medtronic worth $3.29M as of Q2 2026.
- Hengehold Capital Management bought 1,041 Medtronic shares in Q2 2026, an estimated $84K.
- Medtronic made up 0.26% of Hengehold Capital Management's portfolio in Q2 2026, its #67 holding.
- Hengehold Capital Management first reported a position in Medtronic in Q2 2018 and has held it in 33 quarters since.
- Hengehold Capital Management's Medtronic position peaked at $3.88M in Q4 2025.
- 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.